Here’s a roundup of nephrology news over the past couple weeks. Click on the headlines to browse the articles. Or, if you’ve discovered other newsworthy items that may be of interest to our team or your nephrologist peers, we invite you to please share news links in the comments.
The program for this year’s Spring Clinical Meetings (SCM19) will include a presentation on the long-awaited Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines for vascular access.
A new analysis of data in the ERA-EDTA Registry shows that men are affected by kidney failure much more often than women.
People exposed to secondhand smoke even a few days a week had more than 50 percent increased risk of developing kidney disease.
By loading a chelation drug into a nano-sized homing device, researchers have reversed in an animal model the deadliest effects of chronic kidney disease, which kills more people in the United States each year than breast or prostate cancer.
So-called conservative management can ease symptoms without dialysis in some people with kidney disease. But many of them are never given the option.
Almost half of those with severely reduced kidney function, but who are not on dialysis, don’t know they have the disease, the Centers for Disease Control and Prevention reported.
An Israeli digital health start-up called Healthy.io has developed an FDA-cleared at-home smartphone urinalysis test to help people test their kidneys for proteins, a sign of damage to the organ.
Image from www.canstockphoto.com